Clinical implementation of pharmacogenomics (PGx) leads to personalized medicine, which
improves the efficacy, safety, and cost-effectiveness of treatments. Although PGx-based …

In psychiatry, the selection of antipsychotics and antidepressants is generally led by a trial-
and-error approach. The prescribing of these medications is complicated by sub-optimal …

It is anticipated that as the range of drugs for which pharmacogenetic testing becomes
available expands, primary care physicians (PCPs) will become major users of these tests …

Purpose Biomedical databases combining electronic medical records and phenotypic and
genomic data constitute a powerful resource for the personalization of treatment. To …

With the trend towards promoting personalised medicine (PM), the application of
pharmacogenetics and pharmacogenomics (PGx) is of growing importance. For the …

Introduction Racial and ethnic categories are frequently used in pharmacogenetics literature
to stratify patients; however, these categories can be inconsistent across different studies. To …

Background: Personalised medicine (PM) is an innovative way to produce better patient
outcomes by using an individualised or stratified approach to disease and treatment rather …

Recent technological advances in nanomedicine and nanotechnology in parallel with
knowledge accumulated from the clinical translation of disease-and drug-related genomic …

Since the human genome project in 2003, the view of personalized medicine to improve
diagnosis and cure diseases at the molecular level became more real. Sequencing the …

Health-care systems, food supply chains, and society in general are threatened by the
inexorable rise of antimicrobial resistance. This threat is driven by many factors, one of …